These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2185172)

  • 1. Medical management of acute postoperative intraocular pressure rises associated with anterior segment ophthalmic laser surgery.
    Robin AL
    Int Ophthalmol Clin; 1990; 30(2):102-10. PubMed ID: 2185172
    [No Abstract]   [Full Text] [Related]  

  • 2. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
    Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
    Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery.
    Sridharrao B; Badrinath SS
    Br J Ophthalmol; 1989 Nov; 73(11):884-7. PubMed ID: 2690926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride, aplonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy.
    Fourman S
    Arch Ophthalmol; 1988 Mar; 106(3):307-9. PubMed ID: 3345140
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of apraclonidine hydrochloride in laser therapy for glaucoma.
    Robin AL
    Trans Am Ophthalmol Soc; 1989; 87():729-61. PubMed ID: 2562547
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy.
    Robin AL; Pollack IP; deFaller JM
    Arch Ophthalmol; 1987 Sep; 105(9):1208-11. PubMed ID: 3307717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery.
    Brown RH; Stewart RH; Lynch MG; Crandall AS; Mandell AI; Wilensky JT; Schwartz AL; Gaasterland DE; DeFaller JM; Higginbotham EJ
    Ophthalmology; 1988 Mar; 95(3):378-84. PubMed ID: 3050686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy.
    Kitazawa Y; Taniguchi T; Sugiyama K
    Ophthalmic Surg; 1989 Jan; 20(1):49-52. PubMed ID: 2648232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of anterior-segment surgery in Rieger's anomaly.
    Dietlein TS; Jacobi PC; Krieglstein GK
    Ger J Ophthalmol; 1996 Nov; 5(6):439-42. PubMed ID: 9479533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apraclonidine and argon laser trabeculoplasty.
    Ofner S; Samples JR; van Buskirk EM
    Am J Ophthalmol; 1992 Dec; 114(6):778-9. PubMed ID: 1361104
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevention of an acute rise in intraocular pressure following Q-switched Nd:YAG laser iridotomy with clonidine.
    Kitazawa Y; Sugiyama K; Taniguchi T
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(1):13-6. PubMed ID: 2920904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise.
    Dapling RB; Cunliffe IA; Longstaff S
    Br J Ophthalmol; 1994 Jan; 78(1):30-2. PubMed ID: 7906539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effect of diclofenac drops after argon laser trabeculoplasty.
    Herbort CP; Mermoud A; Schnyder C; Pittet N
    Arch Ophthalmol; 1993 Apr; 111(4):481-3. PubMed ID: 8470978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy for the acute postoperative intraocular pressure rise following argon laser trabeculoplasty.
    Ofner S; Van Buskirk EM; Samples JR
    Arch Ophthalmol; 1987 Nov; 105(11):1476-7. PubMed ID: 3675266
    [No Abstract]   [Full Text] [Related]  

  • 19. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
    Threlkeld AB; Assalian AA; Allingham RR; Shields MB
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brimonidine 0.2% to prevent post laser IOP elevation.
    Kasahara N
    Ophthalmology; 2002 May; 109(5):828-9; author reply 829. PubMed ID: 11986075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.